Running News and Research

RSS

Trial lawyers push back on medical malpractice reform

...

23 Sep 2009

Aspect and Bruker BioSpin collaborate to develop a new high performance desktop preclinical MRI system

At the 2009 World Molecular Imaging Congress (WMIC) in Montreal, Aspect Magnet Technologies and Bruker BioSpin, a division of Bruker Corporation (NASDAQ: BRKR), today announced that they have signed a Memorandum of Understanding (MoU) for the development of a high performance desktop preclinical MRI system.

23 Sep 2009

Agilent Technologies and Applied Biosystems to co-market SureSelect system

Agilent Technologies Inc. (NYSE:A) and Applied Biosystems, part of Life Technologies Corp. (NASDAQ:LIFE), today introduced the Agilent SureSelect Target Enrichment System, which is optimized for the SOLiD™ System, a next-generation advanced genomic analysis sequencing platform.

23 Sep 2009

NIH funding helps to boost sales of DNA sequencers

Rapid increase in output from second-generation DNA sequencers has enabled new levels of productivity and new experiments. This, along with funding from the stimulus bill, has caused rapid adoption of these machines, according to healthcare market research firm Kalorama Information, helping to fuel sales of DNA sequencers to $480 million in 2008. In its report "DNA Sequencing Equipment and Services Markets, 2nd Edition," Kalorama says more changes are on the way and will drives sales growth of 19% annually through 2013.

23 Sep 2009

Practice Fusion’s EHR offered to BioReference physicians

Practice Fusion Inc., the fastest growing electronic health record community for physicians in the United States, today announced a partnership with BioReference Laboratories, Inc. (NASDAQ:BRLI), the third largest full service laboratory in the country. The companies will collaborate to distribute Practice Fusion’s EHR to interested BioReference physicians and will integrate BioReference lab results into the Practice Fusion’s system.

23 Sep 2009

Pricing of secondary offering announced by Bruker Corporation

Bruker Corporation (NASDAQ: BRKR) today announced the pricing of an underwritten secondary offering of 13,000,000 shares of its common stock at a price to the public of $9.85 per share.

23 Sep 2009

Oncology Metrics and Altos Solutions to merge

Altos Solutions and Oncology Metrics llc, today announced the planned merger of the two companies, creating a combined technology and knowledge data company serving community-based oncology practices. The merged company will be known as Altos Solutions and will be headquartered in Los Altos, California.

23 Sep 2009

Alpha Orthotics announces launch of its Medial Mid-foot Brace in the U.S.

Splayfoot, also called "fallen arch" occurs when the arch of the foot collapses, with the entire sole of the foot coming into complete or near-complete contact with the ground. An estimated 20%-30% of Americans have this condition where the arch never develops, or collapses in one or both feet.

23 Sep 2009

Carolinas HealthCare System implements Radware's application delivery solutions to prevent network downtime

Radware (Nasdaq: RDWR), the leading provider of integrated application delivery solutions for business-smart networking, today announced that Carolinas HealthCare System (CHS), the largest healthcare system in North and South Carolina, has leveraged Radware's suite of application delivery solutions in an effort to maintain a secure network environment with advanced load balancing capabilities for its extensive hospital system.

22 Sep 2009

Model-Based Design reduces the development time of FES devices

The MathWorks today announced that the Cleveland FES Center, using tools for Model-Based Design, has developed research technology that more quickly restores movement to individuals with neuromuscular disabilities.

22 Sep 2009

UC professor argues on stem cell properties

Before it was learned that matter burns by taking up oxygen, most chemists sought to explain combustion as the release of a mysterious substance, which they named "phlogiston". Phlogiston theory was a conceptual breakthrough that helped chemists conduct experiments and share ideas. Only when it came to pinning down the distinctive physical properties of phlogiston did it become clear that no such thing exists.

22 Sep 2009

Ventus' PROVENT Sleep Apnea Therapy is runner-up at the The Wall Street Journal Technology Innovation Awards

Ventus Medical, a privately-held medical device company focused on improving the lives of patients with sleep-disordered breathing, today announced that the company's PROVENT(R) Sleep Apnea Therapy received the Runners-Up Award in The Wall Street Journal 2009 Technology Innovation Awards, Medical Devices category. The results were published in the September 14, 2009 edition of The Wall Street Journal.

22 Sep 2009

Paralyzed rats can walk and run: UCLA scientists

UCLA researchers have discovered that a combination of drugs, electrical stimulation and regular exercise can enable paralyzed rats to walk and even run again while supporting their full weight on a treadmill.

21 Sep 2009

Bruker declares secondary offering of common stock shares

Bruker Corporation today announced an underwritten public secondary offering of 12,000,000 shares of its common stock by two members of the Laukien family not involved in the Company’s business.

18 Sep 2009

Biopharmaceutical company announces initial public offering

Omeros Corporation today announced the launch of its initial public offering of 6.82 million shares of its common stock. Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system.

18 Sep 2009

Rigel to offer 13,000,000 shares of its common stock at a price to the public of $7.25 per share

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the pricing of an underwritten public offering of 13,000,000 shares of its common stock at a price to the public of $7.25 per share.

18 Sep 2009

SXC Health Solutions to raise $176.6 million from sale of common shares

SXC Health Solutions Corp. ("SXC" or the "Company") (NASDAQ: SXCI, TSX: SXC) announced today the pricing of its previously announced public offering of common shares. Under the offering, SXC will sell 4,500,000 common shares at a price to the public of $41.50 per share.

18 Sep 2009